186 related articles for article (PubMed ID: 34553650)
1. Oral delivery of solid lipid nanoparticles: underlining the physicochemical characteristics and physiological condition affecting the lipolysis rate.
Mahmoudian M; Maleki Dizaj S; Salatin S; Löbenberg R; Saadat M; Islambulchilar Z; Valizadeh H; Zakeri-Milani P
Expert Opin Drug Deliv; 2021 Nov; 18(11):1707-1722. PubMed ID: 34553650
[TBL] [Abstract][Full Text] [Related]
2. Slowing down lipolysis significantly enhances the oral absorption of intact solid lipid nanoparticles.
Yu Z; Fan W; Wang L; He H; Lv Y; Qi J; Lu Y; Wu W
Biomater Sci; 2019 Oct; 7(10):4273-4282. PubMed ID: 31407729
[TBL] [Abstract][Full Text] [Related]
3. Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles.
Yu Z; Fan W; Wang L; Qi J; Lu Y; Wu W
Mol Pharm; 2019 Dec; 16(12):5013-5024. PubMed ID: 31638827
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles: a review on recent perspectives and patents.
Paliwal R; Paliwal SR; Kenwat R; Kurmi BD; Sahu MK
Expert Opin Ther Pat; 2020 Mar; 30(3):179-194. PubMed ID: 32003260
[No Abstract] [Full Text] [Related]
5. The lipid type affects the in vitro digestibility and β-carotene bioaccessibility of liquid or solid lipid nanoparticles.
Helena de Abreu-Martins H; Artiga-Artigas M; Hilsdorf Piccoli R; Martín-Belloso O; Salvia-Trujillo L
Food Chem; 2020 May; 311():126024. PubMed ID: 31855778
[TBL] [Abstract][Full Text] [Related]
6. Control of the gastrointestinal digestion of solid lipid nanoparticles using PEGylated emulsifiers.
Ban C; Jo M; Lim S; Choi YJ
Food Chem; 2018 Jan; 239():442-452. PubMed ID: 28873589
[TBL] [Abstract][Full Text] [Related]
7. Absorption, disposition and pharmacokinetics of solid lipid nanoparticles.
Qi J; Lu Y; Wu W
Curr Drug Metab; 2012 May; 13(4):418-28. PubMed ID: 22443536
[TBL] [Abstract][Full Text] [Related]
8. Solid Lipid Nanoparticles for Topical Drug Delivery: Mechanisms, Dosage Form Perspectives, and Translational Status.
Liu M; Wen J; Sharma M
Curr Pharm Des; 2020; 26(27):3203-3217. PubMed ID: 32452322
[TBL] [Abstract][Full Text] [Related]
9. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
11. Lipid-based carriers: manufacturing and applications for pulmonary route.
Jaafar-Maalej C; Elaissari A; Fessi H
Expert Opin Drug Deliv; 2012 Sep; 9(9):1111-27. PubMed ID: 22724618
[TBL] [Abstract][Full Text] [Related]
12. Solid lipid nanoparticles: a promising tool for insulin delivery.
Mohammadpour F; Kamali H; Gholami L; McCloskey AP; Kesharwani P; Sahebkar A
Expert Opin Drug Deliv; 2022 Dec; 19(12):1577-1595. PubMed ID: 36287584
[TBL] [Abstract][Full Text] [Related]
13. Solid Lipid Nanoparticles: A Promising Nanomaterial in Drug Delivery.
Rajpoot K
Curr Pharm Des; 2019; 25(37):3943-3959. PubMed ID: 31481000
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles for hydrophilic drugs.
Mirchandani Y; Patravale VB; S B
J Control Release; 2021 Jul; 335():457-464. PubMed ID: 34048841
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers.
Lin CH; Chen CH; Lin ZC; Fang JY
J Food Drug Anal; 2017 Apr; 25(2):219-234. PubMed ID: 28911663
[TBL] [Abstract][Full Text] [Related]
16. Solid Lipid Nanoparticles (SLNs): Advancements in Modification Strategies Toward Drug Delivery Vehicle.
Al-Sayadi GMH; Verma A; Choudhary Y; Sandal P; Patel P; Singh D; Gupta GD; Kurmi BD
Pharm Nanotechnol; 2023; 11(2):138-154. PubMed ID: 36305142
[TBL] [Abstract][Full Text] [Related]
17. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
18. Solid lipid nanoparticles coated with cross-linked polymeric double layer for oral delivery of curcumin.
Wang T; Ma X; Lei Y; Luo Y
Colloids Surf B Biointerfaces; 2016 Dec; 148():1-11. PubMed ID: 27588376
[TBL] [Abstract][Full Text] [Related]
19. Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (SLNs).
Wang J; Chen J; Ye N; Luo Z; Lai W; Cai X; Lin Y
Curr Drug Metab; 2012 May; 13(4):447-56. PubMed ID: 22443539
[TBL] [Abstract][Full Text] [Related]
20. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.
Clares B; Calpena AC; Parra A; Abrego G; Alvarado H; Fangueiro JF; Souto EB
Int J Pharm; 2014 Oct; 473(1-2):591-8. PubMed ID: 25102113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
